Borongan, Daniela B.

HRN: 23-87-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2023
CEFTRIAXONE 1G (VIAL)
10/09/2023
10/16/2023
IV
1g
Q12
T/C PID; UTI
Waiting Final Action 
10/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/09/2023
10/16/2023
IV
500mg
Q8
T/C PID
Waiting Final Action 
10/12/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/12/2023
10/19/2023
IV
4.5grams
Q 6hrs
PID
Waiting Final Action 
10/19/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2023
10/21/2023
IV
4.5g
Q6
PID
Waiting Final Action 
10/19/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2023
10/24/2023
IV
4.5
Q6
PID
Waiting Final Action 
10/20/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/20/2023
11/03/2023
IV
500mg
Q8
Pelvic Inflammatory Disease
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: